December 2021 Here’s how readers responded to a You Make the Call question about treatment options for a patient with aggressive blastoid mantle cell lymphoma and high bilirubin . Disclaimer : ASH does not recommend or endorse any specific tests, physicians, products, procedures, or opinions, and disclaims any representation, warranty, or guaranty as to the same. Reliance on any information provided in this article is solely at your own risk.

December 2021 Sandy Kurtin, PhD, ANP-C, AOCN Hematology/Oncology Nurse Practitioner at the University of Arizona Cancer Center and an Assistant Professor of Clinical Medicine and Adjunct Clinical Assistant Professor of Nursing at the University of Arizona

December 2021 Aaron T. Gerds, MD, MS Aaron Gerds, MD, is Deputy Director for Clinical Research at the Cleveland Clinic Taussig Cancer Institute and Associate Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in Cleveland, Ohio.

November 2021 Sandy Kurtin, PhD, ANP-C, AOCN Hematology/Oncology Nurse Practitioner at the University of Arizona Cancer Center and an Assistant Professor of Clinical Medicine and Adjunct Clinical Assistant Professor of Nursing at the University of Arizona   Advanced practitioners (APs) are uniquely positioned within their practices to implement change, and make sure that the changes stick. ASH Clinical News Associate Editor Sandy Kurtin, ANP-C, PhD, invited three AP leaders to speak about their experiences. Jason Astrin, DMSc, MBA, PA-C, DFAAPA, is the director of advanced practice provider services for the US Oncology Network, supported by McKesson, an affiliation of privately held community-oncology practices around the country. Gabrielle Zecha, PA-C, MHA, is the director of advanced practice providers at Seattle Cancer Care Alliance. Mailey Wilks, DNP, APRN, is an outpatient nurse practitioner and physician assistant manager at Cleveland Clinic. Part one of this conversation, published in the October issue of ASH Clinical News , covered how and with whom AP leaders work to effect change in their institutions. In part two, the participants discuss the role of APs in patient experience and ensuring continuity of care.

November 2021 Joseph R. Mikhael, MD, MEd Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center and Chief Medical Officer, International Myeloma Foundation

November 2021 Here’s how readers responded to a You Make the Call question about  management of residual vein thrombosis in a patient with a history of DVT . Disclaimer : ASH does not recommend or endorse any specific tests, physicians, products, procedures, or opinions, and disclaims any representation, warranty, or guaranty as to the same. Reliance on any information provided in this article is solely at your own risk.

November 2021 Jerome Seid, MD ASH Congressional Fellow   The American Society of Hematology (ASH) selected Jerome Seid, MD, as its 2020-2021 ASH Congressional Fellow. The Congressional Fellow program aims to connect hematologists to the policy-making process and educate congressional members and staff about issues that are important to hematologists and their patients. In his final column, Dr. Seid reflects on the past year spent working in the office of Nevada Senator Jacky Rosen .